Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
Results from a Phase 1 First in human Study of Pemivibart: an[...]
02/06/2023 | Press release | Distributed by Public on 02/06/2023 04:34
Please select the service you want to use:
Smartlinks | Societatea Nationala de Transport Gaze Naturale TRANSGAZ SA | Company News | Top Company News | Business Announcement | Energy | Oil and Gas | Oil and Gas Downstream and Midstream Activities | Auction Services | Public Companies | Oil and Gas Transportation Companies | London Stock Exchange (LSE) | Bucharest Stock Exchange (BVB) | Cboe Off Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact